Expanding demand for oligonucleotide therapeutics and GMP-grade reagents drives steady global market expansionAustin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Phosphoramidite Market Size & Growth Analysis ...
In today’s fast-paced and competitive biotechnology landscape, control and speed define success for companies and core labs ...
Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko Avecia, Inc. a leading contract development and ...
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, ...
Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...
TOKYO, Oct. 21, 2025 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, and Gene Tools, LLC ...
Growing Importance of Peptide & Oligonucleotide TherapeuticsPeptides and oligonucleotides are transforming modern medicine.
Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Greetings, and welcome to the Codexis Third Quarter 2025 Earnings ...
Announces signing of $37.8m Supply Assurance Agreement with Merck Organizational changes streamline company and reduce operational expenses Cash runway extended through 2027 REDWOOD CITY, Calif., Nov.
The partnership will accelerate efficient and sustainable manufacturing of high-demand proteins and peptides, such as GLP-1 analogs, for pharmaceutical and biotechnology clients TOKYO ...
Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine hairpins, they increased cholesterol uptake by cells and reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback